BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 22406639)

  • 1. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
    Schmidt AM; Imesch P; Fink D; Egger H
    Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Robot-assisted laparoscopy in the management of recurrent pelvic cancer].
    Jauffret C; Lambaudie E; Bannier M; Buttarelli M; Houvenaeghel G
    Gynecol Obstet Fertil; 2011 Dec; 39(12):674-80. PubMed ID: 21871833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration with curative intent for recurrent uterine malignancies.
    Khoury-Collado F; Einstein MH; Bochner BH; Alektiar KM; Sonoda Y; Abu-Rustum NR; Brown CL; Gardner GJ; Barakat RR; Chi DS
    Gynecol Oncol; 2012 Jan; 124(1):42-7. PubMed ID: 22014627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
    Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
    J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
    Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
    Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
    Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
    Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
    Chiva LM; Lapuente F; Núñez C; Ramírez PT
    Gynecol Oncol; 2009 Apr; 113(1):47-51. PubMed ID: 19176235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration for recurrent endometrial cancer.
    Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
    Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.
    Andikyan V; Khoury-Collado F; Sonoda Y; Gerst SR; Alektiar KM; Sandhu JS; Bochner BH; Barakat RR; Boland PJ; Chi DS
    Gynecol Oncol; 2012 May; 125(2):404-8. PubMed ID: 22285844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exenteration as a primary treatment for locally advanced cervical cancer: long-term results and prognostic factors.
    Forner DM; Lampe B
    Am J Obstet Gynecol; 2011 Aug; 205(2):148.e1-6. PubMed ID: 21640963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
    Morris M; Alvarez RD; Kinney WK; Wilson TO
    Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of total pelvic exenteration for colorectal cancer.
    Nishio M; Sakakura C; Nagata T; Miyashita A; Hamada T; Ikoma H; Kubota T; Nakanishi M; Kimura A; Ichikawa D; Kikuchi S; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Taniguchi H; Sonoyama T; Hagiwara A; Otsuji E
    Hepatogastroenterology; 2009; 56(96):1637-41. PubMed ID: 20214208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
    Zhang Z; Zang R; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary pelvic exenteration in cervical cancer patients.
    Ungar L; Palfalvi L; Novak Z
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S9-12. PubMed ID: 18775558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration for carcinoma of the cervix.
    Ingersoll FM; Ulfelder H
    N Engl J Med; 1966 Mar; 274(12):648-51. PubMed ID: 17926376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.